Hypoglycosylation of alpha-dystroglycan in patients with hereditary IBM due to GNE mutations.
D000328:Adult; D003598:Cytoskeletal Proteins / Q000378:metabolism*; D049030:Dystroglycans; D016326:Extracellular Matrix Proteins / Q000378:metabolism*; D005260:Female; D006031:Glycosylation; D006801:Humans; D007797:Laminin / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000378:metabolism*; D008875:Middle Aged; D009097:Multienzyme Complexes / Q000235:genetics*; D018482:Muscle, Skeletal / Q000378:metabolism*; D009154:Mutation / Q000235:genetics; D018979:Myositis, Inclusion Body / Q000235:genetics / Q000378:metabolism*; D019158:N-Acetylneuraminic Acid / Q000096:biosynthesis; D011485:Protein Binding
D003598:Cytoskeletal Proteins; C483081:DAG1 protein, human; D016326:Extracellular Matrix Proteins; D007797:Laminin; D008562:Membrane Glycoproteins; D009097:Multienzyme Complexes; C482901:UDP-N-acetylglucosamine 2-epimerase - N-acetylmannosamine kinase; C102645:laminin alpha 2; D049030:Dystroglycans; D019158:N-Acetylneuraminic Acid